Research Article
CPH-I and HE4 Are More Favorable Than CA125 in Differentiating Borderline Ovarian Tumors from Epithelial Ovarian Cancer at Early Stages
Table 1
Patient characteristics.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Note: data of age are presented as the median (interquartile range). Abbreviations: = number; FIGO = International Federation of Gynecology and Obstetrics; BOT I+II = borderline ovarian tumors in FIGO stages I and II; EOC I+II = epithelial ovarian cancer in FIGO stages I and II. |